ScinoPharm Taiwan, Ltd. Announces Executive Changes, Effective August 01, 2014
July 10, 2014 at 06:38 pm IST
Share
ScinoPharm Taiwan, Ltd. announced the appointment of Yung-Fa Chen as Senior Vice President of R&D and Chief Technology Officer of the company replaces Jo Shen, effective from August 01, 2014.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
SCINOPHARM TAIWAN, LTD. 
